Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer

Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer

<p>Abstract</p> <p>Background</p> <p>Active-specific immunotherapy used as an adjuvant therapeutic strategy is rather unexplored for cancers with poorly characterized tumor antigens like gastric cancer. The aim of this study was to augment a therapeutic immune response...

Full description

Bibliographic Details
Main Authors:	van den Engel Natasja K, Rüttinger Dominik, Rusan Margareta, Kammerer Robert, Zimmermann Wolfgang, Hatz Rudolf A, Winter Hauke
Format:	Article
Language:	English
Published:	BMC 2011-08-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/9/1/140

Similar Items

Characterization of gastric adenocarcinoma cell lines established from CEA424/<it>SV40 T antigen</it>-transgenic mice with or without a human <it>CEA </it>transgene
by: Hatz Rudolf A, et al.
Published: (2006-03-01)

Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
by: Schendel Dolores J, et al.
Published: (2007-09-01)

Therapeutic Vaccines and Cancer Immunotherapy
by: Darshak Bhatt, et al.
Published: (2020-10-01)

Tumor immune response and immunotherapy in gastric cancer
by: Yoonjin Kwak, et al.
Published: (2020-01-01)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)

DC-Based Vaccines for Cancer Immunotherapy
by: Chunmei Fu, et al.
Published: (2020-11-01)

RNA-Based Vaccines in Cancer Immunotherapy
by: Megan A. McNamara, et al.
Published: (2015-01-01)

Advancements in Tumor Immunotherapy and Cancer Vaccines
Published: (2012)

Therapeutic cancer vaccines and combination immunotherapies involving vaccination
by: Nguyen T, et al.
Published: (2014-10-01)

Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
by: Yuka Igarashi, et al.
Published: (2020-01-01)

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
by: Riccardo Dolcetti, et al.
Published: (2018-05-01)

Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies
by: Helena Magalhães, et al.
Published: (2018-01-01)

From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer
by: David Vrána, et al.
Published: (2018-12-01)

Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
by: Maarten K. Nijen Twilhaar, et al.
Published: (2021-06-01)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
by: Zong Sheng Guo, et al.
Published: (2019-01-01)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
by: Elias J. Sayour, et al.
Published: (2018-09-01)

Yeast-based vaccine approaches to cancer immunotherapy
by: Howland, Shanshan W
Published: (2009)

Active immunotherapy of cancer: An overview of therapeutic vaccines
by: Filipić Brankica, et al.
Published: (2019-01-01)

Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
by: Fox Bernard A, et al.
Published: (2007-03-01)

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
by: Joe Abdo, et al.
Published: (2018-03-01)

Potential role of radiation therapy in augmenting the activity of immunotherapy for gynecologic cancers
by: Son CH, et al.
Published: (2017-10-01)

Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
by: Kwang-Soo Kim, et al.
Published: (2021-04-01)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
by: Lin X, et al.
Published: (2021-03-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
by: Xiao Wei, et al.
Published: (2019-05-01)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
by: Vinod Vijay Subhash, et al.
Published: (2015-01-01)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
by: Marc Mansour, et al.
Published: (2011-08-01)

Engineering dendritic cell vaccines to improve cancer immunotherapy
by: Caleb R. Perez, et al.
Published: (2019-11-01)

In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology
by: Chenkai Mao, et al.
Published: (2020-12-01)

Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
by: Estela Noguera-Ortega, et al.
Published: (2020-07-01)

Trial watch: dendritic cell vaccination for cancer immunotherapy
by: Jenny Sprooten, et al.
Published: (2019-11-01)

Putting into Perspective the Future of Cancer Vaccines: Targeted Immunotherapy
by: Issam Makhoul, et al.
Published: (2020-09-01)

Combination Immunotherapy: Taking Cancer Vaccines to the Next Level
by: Jeremy M. Grenier, et al.
Published: (2018-03-01)

Development of novel DNA based vaccines for cancer immunotherapy
by: Wilson, Erica Barbara
Published: (2004)

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy
by: Benjamin Wolfson, et al.
Published: (2021-05-01)

Dendritic cell vaccine for the effective immunotherapy of breast cancer
by: Jiang Ni, et al.
Published: (2020-06-01)

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines
by: Fox Bernard A, et al.
Published: (2007-11-01)

Ribavirin in Cancer Immunotherapies: Controlling Nitric Oxide Augments Cytotoxic Lymphocyte Function
by: Richard E. Kast
Published: (2003-01-01)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link With Novel Immunotherapy
by: Maria Grazia Rodriquenz, et al.
Published: (2020-05-01)

Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases
by: Kenji Ina, et al.
Published: (2016-04-01)

Live vaccines—a short‐cut to cancer viro‐immunotherapy
by: Thomas C Wirth, et al.
Published: (2020-01-01)